TMO vs VRTX
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | VRTX |
|---|---|---|
| Price | $675.00 | $526.19 |
| Market cap | $249.58B | $133.37B |
| P/E ratio | 36.4 | 30.7 |
| ROE | 13.51% | 23.54% |
| Profit margin | 15.04% | 35.00% |
| Revenue growth | 10.50% | 12.50% |
| Dividend yield | 0.28% | — |
| Beta | 0.85 | 0.32 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs VRTX in plain English
- TMO is the bigger company — about 1.9× the market cap of VRTX.
- VRTX is cheaper on earnings (P/E 30.7 vs 36.4).
- VRTX earns a higher return on equity (24% vs 14%).
- VRTX is growing revenue faster (12% vs 10%).
- TMO pays a dividend (0.28%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.